For patients at risk for thromboembolic complications who have trouble with adherence to warfarin therapy or prefer not to be treated with warfarin, newer direct-acting oral anticoagulants may be an option. Michael A. Evans, BS, RPh, explores the advantages and limitations of treating patients with direct-acting oral anticoagulants.
Mr Evans remarks that unlike with warfarin, regular monitoring is not required with the direct-acting oral anticoagulants, as their anticoagulant effect is predictable. There are no known food interactions with the direct-acting oral anticoagulants; however, drug-drug interactions are still of concern.
The direct-acting oral anticoagulants have a short half-life, and thus missed doses and a lack of patient adherence leave patients at risk for thromboembolic events within a short time frame, says Mr Evans.
Should a patient who is being treated with a direct-acting oral anticoagulant experience a thromboembolic event, it is more difficult to determine whether the event was related to a lack of adherence or drug failure, notes Mr Evans. This may be easier to determine for patients who are treated with warfarin, he adds.
Mr Evans explains that a patient’s age, their risk for bleeding events, and cost are all factors that affect a physician’s decision to treat a patient with warfarin versus a direct-acting oral anticoagulant.
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Untangling Medical Debt From Credit Scores: Effects So Far and Next Steps
November 29th 2023After recent policy changes removing most medical debts from credit reports, Americans are seeing their credit scores increase, but experts warn of the need to monitor billing and collection practices for unintended consequences.
Read More
Allegations call out restrictions on medically necessary care; CDC data highlight surge in COVID-19 deaths and hospitalizations; failure to include additional Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) aid raises concerns over food access.
Read More